Abstract
Various doses of bupropion HCl (Wellbatrin) (5, 10, and 20 mg/kg), a new phenylaminoketone antidepressant, were employed as cues in a two-lever operant discrimination from saline control injections in rats on an FR10 schedule of food reinforcement. Subjects reached and maintained a high level of discrimination in the 0 vs 20 mg/kg bupropion stimulus condition but not at the lower doses. In generalization testing, the following compounds produced dose-related responding on the bupropion lever: viloxazine, nomifensine, caffeine, d-amphetamine, cocaine, methylphenidate, and benzylpiperazine. Drugs that failed to show dose-related generalization included phenethylamine, thyrotropin-releasing hormone, imipramine, nortriptyline, amitriptyline, desipramine, mianserin, chlordiazepoxide, diazepam, scopolamine, phenobarbital, and morphine. With the important exception of viloxazine, the generalization profile of bupropion seems to reflect its previously reported locomotor stimulant effects in the rat rather than its antidepressant activity and suggests that species differences exist between man and rat with regard to the pharmacologic activity of this new antidepressant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barry, H., III: Classification of drugs according to their discriminable effects in rats. Fed. Proc. 33, 1814–1824 (1974)
Colpaert, F. C., Lal, H., Niemegeers, C. J. E., Janssen, P. A. J.: Investigations on drug produced and subjectively experienced discriminative stimuli. I. The fentanyl cue, a tool to investigate subjectively experienced narcotic drug actions. Life Sci. 16, 705–716 (1975)
DiMascio, A., Heninger, G., Klerman, G. I.: Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males. Psychopharmacologia 5, 361–371 (1964)
DiMascio, A., Meyer, R. E., Stifler, L.: Effects of imipramine on individuals varying in level of depression. Am. J. Psychiatry 124, 55–58 (1968)
Fabre, L. F., McLendon, D. M.: Double-blind placebo-controlled study of bupropion hydrochloride (Wellbatrin) in the treatment of depressed inpatients. Curr. Ther. Res. Clin. Exp. 23, 393–402 (1978)
Fann, W. E., Schroeder, D. H., Mehta, N. B., Soroko, F. E., Maxwell, R. A.: Clinical trial of bupropion HCl in treatment of depression. Curr. Ther. Res. Clin. Exp. 23, 222–229 (1978)
Ferris, R. M., White, H., Russell, A., Beaman, O. J., Maxwell, R. A.: The effects of bupropion HCl on uptake of biogenic amines and on inhibition of MAO. Fed. Proc. 37, 481 (1978)
Fielding, S., Lal, H.: Antidepressants. In: Industrial pharmacology, vol. 2. Mount Kisco, NY: Futura Publishing Co. 1975
Greenwood, D. T.: International Vivalan Symposium: Animal pharmacology of viloxazine (vivalan). J. Int. Med. Res. [Suppl.] 3, 18–28 (1975)
Harlow, H. F., Suomi, S. J.: Induced depression in monkeys. Behav. Biol. 12, 273 (1974)
Howard, J. L., Rohrbach, K. W., Pollard, G. T., McBennett, S. T., Jones, C. N.: Comparison of bupropion HCl and imipramine HCl in various operant paradigms. Fed. Proc 37, 481 (1978)
Klerman, G. L.: Relationships between preclinical testing and therapeutic evaluation of antidepressive drugs: The importance of new animal models for theory and practice. In: Predictability in psychopharmacology: Preclinical and clinical correlations. A. Sudilovsky, S. Gershon and B. Beer, eds., pp. 159–178. New York: Raven Press 1975
Lal, H.: Drug-induced discriminable stimuli: Past research and future perspectives. In: Discriminative stimulus properties of drugs, H. Lal, ed., pp. 207–231. New York: Plenum Press 1977a
Lal, H. (ed.) Discriminative stimulus properties of drugs. New York: Plenum Press 1977b
Lapin, I. P.: Comparison of antireserpine and anticholinergic effects of antidepressant and of central and peripheral cholinolytics. In: Antidepressant drugs: Proceedings of the first international symposium, S. Garattini and M. N. G. Dukes, eds., pp. 266–278. New York: Excerpta Medica Foundation 1966
Lehmann, E., Hopes, H.: Differential effects of a single dose of imipramine and lopramine in healthy subjects varying in their level of depression. Prog. Neuro. Psychopharmacol. 1, 155–164 (1977)
Lotti, V. J., Torchiana, M. L., Porter, C. C.: Investigations on the action and mechanism of action of diphenylhydantoin as an antagonist of tetrabenazine and reserpine. Arch. Int. Pharmacodyn. Ther. 203, 107–116 (1973)
Metys, J., Metysova, J.: Relationship between antireserpine and central cholinolytic effects of imipramine-like antidepressants. In: Antidepressant drugs: Proceedings of the first international symposium, S. Garattini and M. N. G. Dukes, eds., pp. 255–265. New York: Excerpta Medica Foundation 1966
Niemegeers, C. J. E.: Antagonism of reserpine-like activity. In: Industrial pharmacology, vol. 2, Antidepressants, S. Fielding and H. Lal, eds., pp. 73–98. Mount Kisco, NY: Futura Publishing Co. 1975
Overton, D. A., Batta, S. K.: Relationship between abuse liability of drugs and their degree of discriminability in the rat. In: Predicting dependence liability of stimulant and depressant drugs, T. Thompson and K. R. Unna, eds., pp. 125–135. Baltimore: University Park Press 1977
Peck, A. W., Bye, C. E., Clubley, M., Henson, T., Riddington, C.: A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects. Br. J. Clin. Pharmacol. 7, 469–478 (1979)
Poldinger, W.: Comparison between imipramine and desipramine in normal subjects and their action in depressive patients. Psychopharmacologia 4, 302–307 (1963)
Porsolt, R. D., Anton, G., Blavet, N., Jalfre M.: Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47, 379–391 (1978)
Rossi, V. G.: Pharmacology of tricyclic antidepressants: A review. Am. J. Pharm. 148, 37–45 (1976)
Scott, J. P., Stewart, J. M., Deghet, V. J.: Separation in infant dogs: Emotional response and motivational consequences. In: Separation and depression: Clinical and research aspects, J. P. Scott and E. C. Senay, eds., p. 3. Washington, D. C.: AAAS 1973
Seligman, M. E. P.: Helplessness: On depression, development and death. San Francisco: Freeman Publishing Co. 1975
Shearman, G., Miksic, S., Lal, H.: Discriminative stimulus properties of desipramine. Neuropharmacology 17, 1045–1048 (1978)
Soroko, F. E., Mehta, N. B., Garvey, M., Ravo, J.: Pharmacology of (±) α-t-butylamino-3-chloro-propiophenone HCl. Fed. Proc. 29, 650 (1970)
Soroko, F. E., Mehta, N. B., Maxwell, R. A., Ferris, R. M., Schroeder, D. H.: Bupropion hydrochloride [(±) α-t-butylamino-3-chloro-propiophenone HCl]: A novel antidepressant agent. J. Pharm. Pharmacol. 29, 767–770 (1977)
Spencer, P. S. J.: Antagonism of hyperthermia in the mouse by antidepressants. In: Antidepressant drugs: Proceedings of the first international symposium, S. Garattini and M. N. G. Dukes, eds., pp. 194–204. New York: Excerpta Medica Foundation 1966
Sulser, F., Soroko, F.: On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine. Psychopharmacologia 8, 191–200 (1965)
Weissman, A.: The discriminability of aspirin in arthritic and non-arthritic rats. Pharmacol. Biochem. Behav. 5, 583–586 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, C.N., Howard, J.L. & McBennett, S.T. Stimulus properties of antidepressants in the rat. Psychopharmacology 67, 111–118 (1980). https://doi.org/10.1007/BF00431964
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431964